Rapiblyk Injection, Powder, Lyophilized, For Solution
Product Images NDC 84381-110

3 FDA label images from Aop Orphan Pharmaceuticals Gmbh · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rapiblyk (NDC 84381-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aop Orphan Pharmaceuticals Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structuralformula (Image11)

Structuralformula (Image11)
Chemical structure of landiolol hydrochloride, showing its molecular components including a benzene ring, ester groups, and a morpholine ring.*
FDA Label Image

Cartion (1141 Ldll300 Carton Spl)

FDA Label Image

Vial (1141 Ldll300 Vial Spl)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.